The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature

2004 ◽  
Vol 30 (2) ◽  
pp. 205-211 ◽  
Author(s):  
Evangelos Paraskevaidis ◽  
Marc Arbyn ◽  
Alexandros Sotiriadis ◽  
Emmanuel Diakomanolis ◽  
Pierre Martin-Hirsch ◽  
...  
Keyword(s):  
Systematic Review ◽  
Review Of The Literature ◽  
Dna Testing ◽  
Hpv Dna ◽  
Hpv Dna Testing

scholarly journals Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update

2016 ◽  
Vol 23 (2) ◽  
pp. 109 ◽  
Author(s):  
L. Elit ◽  
E.B. Kennedy ◽  
A. Fyles ◽  
U. Metser
Keyword(s):  
Systematic Review ◽  
Cervical Cancer ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Evidence Based ◽  
Dna Testing ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Evidence Based Care

Background In 2009, the Program in Evidence-based Care (pebc) of Cancer Care Ontario published a guideline on the follow-up of cervical cancer. In 2014, the pebc undertook an update of the systematic review and clinical practice guideline for women in this target population.Methods The literature from 2007 to August 2014 was searched using medline and embase [extended to 2000 for studies of human papillomavirus (hpv) dna testing]. Outcomes of interest were measures of survival, diagnostic accuracy, and quality of life. A working group evaluated the need for changes to the earlier guidelines and incorporated comments and feedback from internal and external reviewers.Results One systematic review and six individual studies were included. The working group concluded that the new evidence did not warrant changes to the 2009 recommendations, although hpv dna testing was added as a potentially more sensitive method of detecting recurrence in patients treated with radiotherapy. Comments from internal and external reviewers were incorporated.Recommendations Summary Follow-up care after primary treatment should be conducted and coordinated by a physician experienced in the surveillance of cancer patients. A reasonable follow-up strategy involves visits every 3–4 months within the first 2 years, and every 6–12 months during years 3–5. Visits should include a patient history and complete physical examination, with elicitation of relevant symptoms. Vaginal vault cytology examination should not be performed more frequently than annually. Combined positron-emission tomography and computed tomography, other imaging, and biomarker evaluation are not advocated; hpv dna testing could be useful as a method of detection of recurrence after radiotherapy. General recommendations for follow-up after 5 years are also provided. 

Three-Year Follow-up for Women 30 Years and Older with Negative Pap and Negative Hybrid Capture 2 HPV DNA Testing Results

2012 ◽  
Vol 1 (1) ◽  
pp. S40
Author(s):  
Marilyn Dawlett ◽  
Teresa Kologinczak ◽  
Jian-Ping Wang ◽  
Nour Sneige ◽  
Therese Bevers ◽  
...  
Keyword(s):  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2

scholarly journals Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study

PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e90023 ◽  
Author(s):  
Maria Persson ◽  
K. Miriam Elfström ◽  
Sophia Brismar Wendel ◽  
Elisabete Weiderpass ◽  
Sonia Andersson
Keyword(s):  
Population Based ◽  
Dna Testing ◽  
Population Based Study ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Cytological Abnormalities

Cervical Cancer Screening

2008 ◽  
Vol 6 (1) ◽  
pp. 58 ◽  
Author(s):  
_ _
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Current Method ◽  
Dna Testing ◽  
Abnormal Cytology ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Recent Version

Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed. For the most recent version of the guidelines, please visit NCCN.org

scholarly journals Role of follow-up imaging after resection of brain arteriovenous malformations in pediatric patients: a systematic review of the literature

2017 ◽  
Vol 19 (2) ◽  
pp. 149-156 ◽  
Author(s):  
Joaquin E. Jimenez ◽  
Zachary C. Gersey ◽  
Jason Wagner ◽  
Brian Snelling ◽  
Sudheer Ambekar ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pediatric Patients ◽  
Surgical Removal ◽  
Review Of The Literature ◽  
Brain Arteriovenous Malformation ◽  
Integral Role ◽  
Meta Analyses ◽  
Mesh Database

OBJECTIVE Pediatric patients are at risk for the recurrence of brain arteriovenous malformation (AVM) after resection. While there is general consensus on the importance of follow-up after surgical removal of an AVM, there is a lack of consistency in the duration of that follow-up. The object of this systematic review was to examine the role of follow-up imaging in detecting AVM recurrence early and preventing AVM rupture. METHODS This systematic review was performed using articles obtained through a search of the literature contained in the MeSH database, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. RESULTS Search results revealed 1052 articles, 13 of which described 31 cases of AVM recurrence meeting the criteria for inclusion in this study. Detection of AVM occurred significantly earlier (mean ± SD, 3.56 ± 3.67 years) in patients with follow-up imaging than in those without (mean 8.86 ± 5.61 years; p = 0.0169). While 13.34% of patients who underwent follow-up imaging presented with rupture of a recurrent AVM, 57.14% of those without follow-up imaging presented with a ruptured recurrence (p = 0.0377). CONCLUSIONS Follow-up imaging has an integral role after AVM resection and is sometimes not performed for a sufficient period, leading to delayed detection of recurrence and an increased likelihood of a ruptured recurrent AVM.

The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions

2008 ◽  
Vol 137 (1) ◽  
pp. 88-91 ◽  
Author(s):  
Paulo C. Giraldo ◽  
Jose Eleutério ◽  
Diane Isabelle M. Cavalcante ◽  
Ana Katherine S. Gonçalves ◽  
Juliana A.A. Romão ◽  
...  
Keyword(s):  
High Risk ◽  
Sexual Partners ◽  
Dna Testing ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Male Sexual Partners ◽  
High Risk Hpv
Sign in / Sign up

Export Citation Format

Share Document